Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of tenofovir alafenamide in patients with prior tenofovir disoproxil fumarate tubulopathy
2016-003345-29Phase 4Unknown
- Sponsor
- King's College Hospital
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tenofovir alafenamide in human immunodeficiency virus infection (HIV) (2 arms), sponsored by King's College Hospital. Status: unknown.
02
Drugs
tenofovir alafenamide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2016-003345-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003345-29.